Previous 10 | Next 10 |
The pandemic has demonstrated how drugmakers can quickly and effectively harness medical innovations. Advances in genetic sequencing underpin many advancements in life sciences, and the sequencing of millions of DNA codes has become cheaper and easier. Given the remarkable groundb...
Almost every commodity rose in prices last week, as did the dollar. Those two factors - rising dollar and rising commodity prices - mean the likelihood of recession in the coming year has risen significantly in just the last week. There was considerable volatility in stocks last week,...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
We think that the inflection point is now. The past 18 months have accelerated the use of technology both on the consumer and business side - whether it’s in e-commerce, digital banking, or clean energy. Companies that do not have sunk capital in legacy business models are ofte...
Russia’s invasion of Ukraine, the biggest conventional military attack in Europe since World War II, has wide-ranging implications for economies and markets around the world. Disruptions from this war and the higher energy prices that result could significantly dampen Europe...
The goal of the DDM is to quickly and easily utilize available resources of an asset to understand what the intrinsic value of that asset is based on certain market and company expectations. If the required return component of the equation rises without expectations of higher company ...
The anticipated end of the pandemic causes volatility because a transition phase will be priced as a new rotation from, for example, defensive staples to healthcare. Healthcare ETFs can add a defense to a portfolio that is overweight cyclicals, energy, and financials. US Airlines ...
At the end of 2019, had we been told that a two-year pandemic was about to begin, we would have found it impossible to predict the set of returns that followed in subsequent years. Historically, “tightening,” or “over-tightening,” policy was about corrallin...
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - $0.1938. 30-Day SEC Yield of 0.79% as of Dec. 16. Payable Dec 23; for shareholders of record Dec 21; ex-div Dec 20. For further details see: SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1938
Aeta: We know the transmissibility is higher for the omicron variant and will impact vaccine efficacy, but anecdotal hospital reports suggest that it milder. Aeta: Health care is having a solid year but is still lagging the market, as cyclicals are outperforming due to the strong econ...
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
Second Quarter 2024 Highlights: Record sales of $3.61 billion, up 18% in U.S. dollars and 11% organically compared to the second quarter of 2023 GAAP Diluted EPS of $0.41, up 11% compared to prior year Record Adjusted Diluted EPS of $0.44, up 22% compared to prior year ...
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...